Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clareon Toric Study (T2-T9)

NCT: NCT06285695 · COMPLETED

NCT IDNCT06285695
StatusCOMPLETED
Start Date2024-04-10
Completion2026-06-25
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).

Frequently Asked Questions

What is Clareon Toric Study (T2-T9)?

Clareon Toric Study (T2-T9) is a clinical trial registered under NCT06285695. Current status: COMPLETED.

What is the status of NCT06285695?

The current status of NCT06285695 (Clareon Toric Study (T2-T9)) is: COMPLETED.

When did Clareon Toric Study (T2-T9) start?

Clareon Toric Study (T2-T9) started on 2024-04-10.

Related Devices

K161794CENTURION Vision System (Active SentryTM)Alcon Research, Ltd. K170520HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+Alcon Research, Ltd. K191650LEGION SystemAlcon Research, LLC PMA P040020Lens, multifocal intraocularAlcon Research, Ltd. PMA P150037Intraocular pressure lowering implantAlcon Research, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑